In addition to all of your molecular testing needs, GenPath also provides state-of-the-art coagulation testing services for your patients. Over 100 advanced assays and panels are available and analyzed by our expert in-house medical staff led by De-Hui Wayne Ku, PhD.To view a comprehensive listing of all tests offered by GenPath, please visit our Test Directory or download our Coagulation Requisition.
SAMPLE OF SPECIAL COAGULATION TESTS OFFERED
Complete Blood Count (CBC)Complete blood count (CBC) testing is beneficial in detecting cancer and monitoring cancer treatment in patients. CBC tests can be used as a diagnostic tool for leukemia, anemia, and other hematological disorders. A CBC measures the amount and ratio of blood cell types circulating in the bloodstream. Changes in these numbers can indicate disease progression or response to treatment.
PT, PTTProthrombin time (PT) and partial thromboplastin time (PTT) tests evaluate hemostasis . They measure coagulation factor efficiency by the amount of time it takes for plasma to clot PT and PTT can help monitor cancer treatment and anticoagulant medications.
Thrombophilia AssessmentThrobophilia assessments are useful in monitoring patients more susceptible to excessive clotting. For example, ponatinib, a FDA approved therapy for CML and Ph+ ALL, can increase the risk of developing blood clots in the blood vessels* so the throbophilia assessment will help with treatment management for this patient population. *Adult CML and Ph+ ALL patients with T3151 mutations or for whom no other TKI is indicated
D-Dimer TestThe D-Dimer test is used to rule out abnormal blood clotting. It measures the amount of D-Dimer released when a blood clot breaks up. A study in Haematologica found that high D-Dimer levels are associated with a poor prognosis for cancer patients (2012) due to activating the patient€™s hemostatic system.
SPECIAL COAGULATION PANELS
Abnormal aPTT Assessment
Abnormal PT & aPTT Assessment
Abnormal PT Solely
Antiphospholipid Antibody & Lupus Inhibitor Assessment – Basic
Antiphospholipid Antibody & Lupus Inhibitor Assessment – Expanded
Arterial & Atherothrombotic Risk – Basic
Arterial & Atherothrombotic Risk – Expanded
Bleeding Diathesis Evaluation
General Thrombophilia Assessment for Inherited & Acquired Disorders
Fibrinolytic Evaluation – Standard
For Specific Factor Inhibitor
Lupus Inhibitor Screen
Hyperactive Coagulation Panel
Pregnancy Thrombophilia Assessment
Venous Prothrombotic Risk Factor
von Willebrand Screen – Basic
von Willebrand Screen – Expanded